Search results
Results from the WOW.Com Content Network
Text messages, a whistleblower lawsuit and an internal investigation reveal the lengths to which Medtronic, the world’s largest medical device company, allegedly “groomed” doctors to overuse ...
Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), is a United States Supreme Court case in which the Court held that the pre-emption clause of the Medical Device Amendment bars state common-law claims that challenge the effectiveness or safety of a medical device marketed in a form that received premarket approval from the Food and Drug Administration.
Medtronic (NYS: MDT) announced Wednesday that it is offering a $2.5 million grant to Yale researchers who will independently review the safety of the company's controversial Infuse bone graft product.
When Army physician Timothy R. Kuklo was trying to get his study of Medtronic Inc.'s (MDT) Infuse bone-graft product published, he didn't say a word that he had received $800,000 from the medical ...
In 2005, Michelson sold many of his spine-related patents to Medtronic for $1.35 billion, [13] placing him on the Forbes 400 list. [14] A legal battle with Medtronic over the origins of the patents preceded the sale. In 2004, Michelson cross-filed in response to Medtronic's 2001 suit, and was awarded financial damages for both lawsuits by the ...
Eli Lilly and Company v. Medtronic, Inc., 496 U.S. 661 (1990), is a United States Supreme Court case related to patent infringement in the medical device industry. It held that 35 U.S.C. § 271(e)(1) [1] of United States patent law exempted premarketing activity conducted to gain approval of a device under the Federal Food, Drug, and Cosmetic Act from a finding of infringement.
Medtronic operational headquarters in Fridley, Minnesota, a suburb of Minneapolis. Medtronic was founded in 1949 in Minneapolis by Earl Bakken and his brother-in-law, Palmer Hermundslie, as a medical equipment repair shop. [8] Bakken invented several medical technology devices that continue to be used around the world today. [citation needed]
Medtronic is upping the ante in patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic's InterStim device, an implanted ...